Med approved for the treatment of excessive daytime sleepiness associated with obstructive sleep apnoea in adults
Med approved for the treatment of excessive daytime sleepiness associated with obstructive sleep apnoea in adults
The FDA will likely make a formal decision on the use of the vaccine in this age group in the coming days
More than 85 million vaccines have already been delivered and nine in ten adults have had their first dose
There is currently no cure for lupus, and many of the existing therapies have shown varying degrees of success
Partnership will see DNAe, Imperial College London and the University of Leicester collaborate on early detection of recurrent breast cancer
Novartis is eyeing approval for Kymriah to treat adult patients with relapsed or refractory follicular lymphoma
The development of the device is being carried out by Aptar Pharma’s Digital Health group
Opposition leaders have emphasised that more than 100,000 people eligible for a third dose have not yet received it
First oral GnRH antagonist to be licensed in Great Britain for these women
The drug acts by inhibiting SARS-CoV-2 from replicating in the human system
Tucatinib, a tyrosine kinase inhibitor, works by blocking a specific area of the HER2 gene in cancer cells
Product designed to allow laboratories to expand in-house oncology research
Approval covers patients with locally recurrent or metastatic TNBC
Package was announced during a speech at the annual Conservative Party Conference in Manchester, UK
Javid also announced the government’s ‘five pillar’ plan for addressing COVID-19 during the challenging winter months